Acupuncture and Gonadotropin-releasing Hormone Pulse Generator and Stress Axis in Polycystic Ovary Syndrome (PCOSLFEA)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Hypothesis The overall hypothesis is that non-obese (BMI <30) women with PCOS have high luteinising hormone (LH) and cortisol pulse frequency and amplitude and that repeated low-frequency EA restore these alterations and induce ovulation.
| Condition | Intervention |
|---|---|
|
Polycystic Ovary Syndrome |
Device: Low-frequency electro-acupuncture (EA) Other: Meeting a therapist - attention control |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Does Low-frequency Electro-acupuncture Restore Sensitivity of the Gonadotropin-releasing Hormone Pulse Generator and Stress Axis in Polycystic Ovary Syndrome |
- Frequent blood sampling every 10th minute during an overnight stay in order to measure changes in LH and cortisol pulsatility before and after treatment. A third assessment will be made in those participants who ovulate during the 14 week study. [ Time Frame: 16 weeks ] [ Designated as safety issue: Yes ]
- Ovulation, health related quality of life [ Time Frame: 16 weeks ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 28 |
| Study Start Date: | February 2009 |
| Study Completion Date: | December 2010 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Low-frequency electro-acupuncture |
Device: Low-frequency electro-acupuncture (EA)
2 Hz EA during 30 minutes, twice a week, 14 weeks.
|
| Active Comparator: Meeting a therapist - attention |
Other: Meeting a therapist - attention control
Meeting a therapist, twice a week during 30 minutes in order to control for the increased amount of attention.
|
Detailed Description:
Aim 1. Elucidate if low-frequency EA induce ovulation and restore LH frequency and amplitude as well as sex steroid secretion as compared to a control group receiving same amount of attention.
Aim 2. Elucidate if low-frequency EA restore cortisol frequency and amplitude compared to a control group receiving same amount of attention.
Aim 3. Elucidate if low-frequency EA restore psychological distress and quality of life as compared to a control group receiving same amount of attention.in women with PCOS.
Eligibility| Ages Eligible for Study: | 18 Years to 39 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 18 - 39 years, inclusive
- 30 ≤ BMI
- History of irregular menstrual cycles
- Clinical and/or biochemical androgen excess (determined during screening)
Exclusion Criteria:
Medical Exclusion Criteria
- History or clinical manifestation of; cardiovascular disease, diabetes (Type 1 or Type 2), any other significant endocrine or metabolic disorder.
- Regular use of medications for weight control, psychosis and thyroid disease. A 3 month washout period will be permitted for contraceptives.
Psychiatric and Behavioral Exclusion Criteria
- Pregnant or breast-feeding women
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Elisabet Stener-Victorin, PhD, Researcher, Göteborg University |
| ClinicalTrials.gov Identifier: | NCT00921492 History of Changes |
| Other Study ID Numbers: | PCOSLFEA-17611, 2008-72VP-15445-01A, ALFFGBG-10984 |
| Study First Received: | June 12, 2009 |
| Last Updated: | October 6, 2011 |
| Health Authority: | Sweden: Regional Ethical Review Board Sweden: Swedish Research Council |
Keywords provided by Göteborg University:
|
Luteinizing hormone Cortisol HPA axis HPO axis |
Ovulation Heart rate variability Psychological distress and quality of life |
Additional relevant MeSH terms:
|
Polycystic Ovary Syndrome Ovarian Cysts Cysts Neoplasms Ovarian Diseases Adnexal Diseases Genital Diseases, Female |
Gonadal Disorders Endocrine System Diseases Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 22, 2013